Engineering vascularized bone: Osteogenic and proangiogenic potential of murine periosteal cells

Stem Cells

Volumn 30, Issue 11, 2012, Pages 2460-2471

  Van Gastel, Nick ^a   Torrekens, Sophie ^a   Roberts, Scott J ^a   Moermans, Karen ^a   Schrooten, Jan ^a   Carmeliet, Peter ^a,b   Luttun, Aernout ^a   Luyten, Frank P ^a   Carmeliet, Geert ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Angiogenesis; Hematopoiesis; Osteogenesis; Periosteum; Stem cells; Tissue engineering

Indexed keywords

CALCIUM PHOSPHATE; COLLAGEN; STEM CELL ANTIGEN 1; VASCULOTROPIN;

ADIPOGENESIS; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BONE CELL; BONE DEVELOPMENT; BONE TISSUE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CHONDROGENESIS; ENDOTHELIUM CELL; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG BONE; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PERICYTE; PERIOSTEUM; PHENOTYPE; PRIMARY CELL CULTURE; STROMA; TISSUE ENGINEERING;

ANIMALS; ANTIGENS, CD; BONE AND BONES; BONE REGENERATION; BONE SUBSTITUTES; CALCIUM PHOSPHATES; CELL DIFFERENTIATION; CELL HYPOXIA; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; PERIOSTEUM; PRIMARY CELL CULTURE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84867913813     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1210     Document Type: Article

References (61)

1. Giannoudis PV, Dinopoulos H, Tsiridis E. Bone substitutes: An update. Injury 2005;36:S20-S27.
2. Bueno EM, Glowacki J. Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol 2009;12:685-697.
3. Khosla S, Westendorf JJ, Modder UI. Concise review: Insights from normal bone remodeling and stem cell-based therapies for bone repair. Stem Cells 2010;12:2124-2128.
4. Satija NK, Singh VK, Verma YK et al. Mesenchymal stem cell-based therapy: A new paradigm in regenerative medicine. J Cell Mol Med 2009;11-12:4385-4402.
5. Arnsdorf EJ, Jones LM, Carter DR et al. The periosteum as a cellular source for functional tissue engineering. Tissue Eng Part A 2009;9:2637-2642.
6. Hutmacher DW, Sittinger M. Periosteal cells in bone tissue engineering. Tissue Eng 2003;9:S45-S64. (Pubitemid 37046606)
7. Eyre-Brook AL. The periosteum: Its function reassessed. Clin Orthop Relat Res 1984;189:300-307. (Pubitemid 14024487)
8. Colnot C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res 2009;2:274-282.
9. Gerstenfeld LC, Cullinane DM, Barnes GL et al. Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003;5:873-884. (Pubitemid 36337032)
10. Ozaki A, Tsunoda M, Kinoshita S et al. Role of fracture hematoma and periosteum during fracture healing in rats: Interaction of fracture hematoma and the periosteum in the initial step of the healing process. J Orthop Sci 2000;1:64-70. (Pubitemid 30133793)
11. De Bari C, Dell'Accio F, Vanlauwe J et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006;4:1209-1221. (Pubitemid 43672933)
12. Yoshimura H, Muneta T, Nimura A et al. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 2007;3:449-462. (Pubitemid 46232315)
13. Bakker AD, Schrooten J, van Cleynenbreugel T et al. Quantitative screening of engineered implants in a long bone defect model in rabbits. Tissue Eng Part C Methods 2008;3:251-260.
14. Perka C, Schultz O, Spitzer RS et al. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. Biomaterials 2000;11:1145-1153. (Pubitemid 30173153)
15. Sakata Y, Ueno T, Kagawa T et al. Osteogenic potential of cultured human periosteum-derived cells - A pilot study of human cell transplantation into a rat calvarial defect model. J Craniomaxillofac Surg 2006;8:461-465. (Pubitemid 44890788)
16. Grellier M, Bordenave L, Amedee J. Cell-to-cell communication between osteogenic and endothelial lineages: Implications for tissue engineering. Trends Biotechnol 2009;10:562-571.
17. Lu C, Miclau T, Hu D et al. Ischemia leads to delayed union during fracture healing: A mouse model. J Orthop Res 2007;1:51-61. (Pubitemid 46070731)
18. Macnab I, De Haas WG. The role of periosteal blood supply in the healing of fractures of the tibia. Clin Orthop Relat Res 1974;105:27-33.
19. Giannoni P, Scaglione S, Daga A et al. Short-time survival and engraftment of bone marrow stromal cells in an ectopic model of bone regeneration. Tissue Eng Part A 2010;2:489-499.
20. Hu XY, Yu SP, Fraser JL et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 2008;4:799-808. (Pubitemid 351417929)
21. Santos MI, Reis RL. Vascularization in bone tissue engineering: Physiology, current strategies, major hurdles and future challenges. Macromol Biosci 2010;1:12-27.
22. Maes C, Goossens S, Bartunkova S et al. Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones. EMBO J 2010;2:424-441.
23. Maes C, Kobayashi T, Selig MK et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell 2010;2:329-344.
24. Wan C, Gilbert SR, Wang Y et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci USA 2008;2:686-691. (Pubitemid 351171769)
25. Au P, Tam J, Fukumura D et al. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008;9:4551-4558.
26. Unger RE, Sartoris A, Peters K et al. Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. Biomaterials 2007;27:3965-3976. (Pubitemid 47048370)
27. Coenegrachts L, Maes C, Torrekens S et al. Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation. Cancer Res 2010;16:6537-6547.
28. Hendrickx B, Verdonck K, Van den Berge S et al. Integration of blood outgrowth endothelial cells in dermal fibroblast sheets promotes full thickness wound healing. Stem Cells 2010;7:1165-1177.
29. Lundberg P, Allison SJ, Lee NJ et al. Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem 2007;26:19082-19091. (Pubitemid 47100173)
30. Maes C, Stockmans I, Moermans K et al. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 2004;2:188-199. (Pubitemid 38544204)
31. Masuyama R, Stockmans I, Torrekens S et al. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 2006;12:3150-3159. (Pubitemid 44878629)
32. Nakahara H, Goldberg VM, Caplan AI. Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res 1991;4:465-476.
33. Allen P, Melero-Martin J, Bischoff J. Type I collagen, fibrin and Pura- Matrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networks. J Tissue Eng Regen Med 2011;4:E74-E86.
34. Maes C, Carmeliet P, Moermans K et al. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 2002;1-2:61-73. (Pubitemid 34136979)
35. Rabau MY, Dayan D. Polarization microscopy of picrosirius red stained sections - A useful method for qualitative evaluation of intestinal wall collagen. Histol Histopathol 1994;3:525-528. (Pubitemid 24234459)
36. De Bari C, Dell'Accio F, Luyten FP. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum 2001;1:85-95. (Pubitemid 32113122)
37. Bonyadi M, Waldman SD, Liu DM et al. Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci USA 2003;10:5840-5845. (Pubitemid 36576895)
38. Morikawa S, Mabuchi Y, Kubota Y et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 2009;11:2483-2496.
39. Han D, Zhang Q. An essential requirement for osteoclasts in refined bone-like tissue reconstruction in vitro. Med Hypotheses 2006;1:75-78.
40. Brighton CT, Krebs AG. Oxygen tension of healing fractures in the rabbit. J Bone Joint Surg Am 1972;2:323-332.
41. Gerber HP, McMurtrey A, Kowalski J et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase Akt signal transduction pathway - Requirement for Flk-1/KDR activation. J Biol Chem 1998;46:30336-30343. (Pubitemid 28545503)
42. Nor JE, Christensen J, Mooney DJ et al. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999;2:375-384. (Pubitemid 29094088)
43. Grcevic D, Pejda S, Matthews BG et al. In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells 2012;2:187-196.
44. Sakaguchi Y, Sekiya I, Yagishita K et al. Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Rheum 2005;8:2521-2529. (Pubitemid 41117441)
45. Wang Q, Huang C, Zeng F et al. Activation of the Hh pathway in periosteum-derived mesenchymal stem cells induces bone formation in vivo: Implication for postnatal bone repair. Am J Pathol 2010;6: 3100-3111.
46. Fan W, Crawford R, Xiao Y. Structural and cellular differences between metaphyseal and diaphyseal periosteum in different aged rats. Bone 2008;1:81-89. (Pubitemid 350297182)
47. Lu CY, Miclau T, Hu D et al. Cellular basis for age-related changes in fracture repair. J Orthop Res 2005;6:1300-1307. (Pubitemid 41554661)
48. Naik AA, Xie C, Zuscik MJ et al. Reduced COX-2 expression in aged mice is associated with impaired fracture healing. J Bone Miner Res 2009;2:251-264.
49. Seeman E. The periosteum - A surface for all seasons. Osteoporos Int 2007;2:123-128. (Pubitemid 46090217)
50. Lu CY, Hansen E, Sapozhnikova A et al. Effect of age on vascularization during fracture repair. J Orthop Res 2008;10:1384-1389.
51. Robey PG. Cell sources for bone regeneration: The good, the bad, and the ugly (but promising). Tissue Eng Part B Rev 2011;6:423-430.
52. Kuznetsov SA, Krebsbach PH, Satomura K et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997;9:1335-1347. (Pubitemid 27375376)
53. Miura Y, Gao Z, Miura M et al. Mesenchymal stem cell-organized bone marrow elements: An alternative hematopoietic progenitor resource. Stem Cells 2006;11:2428-2436. (Pubitemid 44674303)
54. Sacchetti B, Funari A, Michienzi S et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007;2:324-336. (Pubitemid 47592917)
55. Roberts SJ, Geris L, Kerckhofs G et al. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. Biomaterials 2011;19:4393-4405.
56. Zhang X, Xie C, Lin AS et al. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: Implications for functional tissue engineering. J Bone Miner Res 2005;12:2124-2137. (Pubitemid 41698776)
57. Peled A, Zipori D, Abramsky O et al. Expression of alpha-smooth muscle actin in murine bone-marrow stromal cells. Blood 1991;2:304-309.
58. Crisan M, Yap S, Casteilla L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3:301-313.
59. Coutu DL, Francois M, Galipeau J. Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. Blood 2011;25:6801-6812.
60. Diaz-Flores L, Gutierrez R, Lopez-Alonso A et al. Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis. Clin Orthop Relat Res 1992;275:280-286.
61. Simpson AHRW. The blood-supply of the periosteum. J Anat 1985;140:697-704.